The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathology

The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathology

Background: Faecal occult blood test (FOBT) has demonstrated effectiveness in colorectal cancer (CRC) screening. Faecal calprotectin (FC) has proven efficient for evaluating activity in inflammatory bowel disease (IBD), but its value in CRC detection is less established. Most symptomatic patients ha...

Full description

Bibliographic Details
Main Authors: Alberto Lué, Gonzalo Hijos, Carlos Sostres, Alba Perales, Mercedes Navarro, Maria Victoria Barra, Barbara Mascialino, Carmen Andalucia, Juan José Puente, Ángel Lanas, Fernando Gomollon
Format: Article
Language:English
Published: SAGE Publishing 2020-05-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/1756284820920786

Internet

https://doi.org/10.1177/1756284820920786

Similar Items